CLARK IAN T
SEC Form 4 insider trading activity
CLARK IAN T has filed 7 SEC Form 4 filings (21 transaction rows) across 4 companies, including GH, BMRN, KYTX, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Aug 5, 2026.
On the most recent filing, CLARK IAN T is listed as Director at Guardant Health, Inc. Inside the rolling window, CLARK IAN T reported no open-market purchases and 4 open-market sales totaling $13.9M in GH and OLMA. The largest disclosed transaction in the window is a sale of 264,800 OLMA shares on Dec 19, 2025, worth $7.9M.
Companies traded
Other insiders at GH
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$13.9M
reported sales (SEC code S)
Companies
4
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has CLARK IAN T made?
CLARK IAN T has filed 7 SEC Form 4 filings (21 transaction rows) across 4 companies, including GH, BMRN, KYTX since 2025.
Which companies does CLARK IAN T trade?
CLARK IAN T has filed SEC Form 4 disclosures for 4 companies, including GH, BMRN, KYTX.
When was CLARK IAN T's most recent SEC Form 4 filing?
CLARK IAN T's most recent SEC Form 4 filing on Tracefour is dated Aug 5, 2026.
What is CLARK IAN T's total buy and sell value in the current window?
Inside the rolling retention window, CLARK IAN T bought $0 and sold $13.9M based on SEC Form 4 filings.
What was CLARK IAN T's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 264,800 OLMA shares on 2025-12-19, worth $7.9M, per SEC Form 4 filings.